US Stock MarketDetailed Quotes

LGND Ligand Pharmaceuticals

Watchlist
  • 105.652
  • -3.648-3.34%
Trading Mar 11 12:22 ET
2.03BMarket Cap-480.24P/E (TTM)

About Ligand Pharmaceuticals Company

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Company Profile

SymbolLGND
Company NameLigand Pharmaceuticals
Listing DateNov 17, 1992
Issue Price11.00
Founded1987
CEOMr. Todd C. Davis
MarketNASDAQ
Employees68
Fiscal Year Ends12-31
Address555 Heritage Drive,Suite 200
CityJupiter
ProvinceFlorida
CountryUnited States of America
Zip Code33458
Phone1-858-550-7500
Websitehttp://www.ligand.com

Company Executives

  • Name
  • Position
  • Salary
  • Todd C. Davis
  • Chief Executive Officer and Director
  • 6.22M
  • Octavio Espinoza
  • Chief Financial Officer and Principal Accounting Officer
  • 2.45M
  • Andrew Reardon
  • Chief Legal Officer and Secretary
  • 2.34M
  • Dr. John W. Kozarich,PhD
  • Chairman of the Board
  • 361.70K
  • Dr. John L. LaMattina, PhD
  • Independent Director
  • 329.20K
  • Dr. Nancy Ryan Gray, PhD
  • Independent Director
  • 339.20K
  • Dr. Stephen L. Sabba,M.D.
  • Independent Director
  • 341.70K
  • Martine Zimmermann, Pharm.D.
  • Independent Director
  • 467.87K
  • Jason M. Aryeh
  • Independent Director
  • 339.20K
  • Jason Haas
  • Independent Director
  • 346.70K

Trending Stocks

Market Hot Picks Market Hot Picks
No. Symbol Price
Tesla
TSLA
226.925
NVIDIA
NVDA
108.475
Palantir
PLTR
78.440
4
Apple
AAPL
220.130
5
Advanced Micro Devices
AMD
96.025
Log In for the Full List
Unlock Now